# Treatment of Freckles by Intradermal Tranexamic Acid Versus Q Switched KTP Laser.

> **NCT03885895** · PHASE1 · UNKNOWN · sponsor: **Kasr El Aini Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Therapeutic Efficacy

## Interventions

- **DRUG:** Tranexamic Acid Injectable Product
- **DEVICE:** Q switched KTP (532nm)

## Key facts

- **NCT ID:** NCT03885895
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-15
- **Primary completion:** 2019-08
- **Final completion:** 2019-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03885895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03885895, "Treatment of Freckles by Intradermal Tranexamic Acid Versus Q Switched KTP Laser.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03885895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*